Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
Article in Acta Pharmaceutica Sinica B (November 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Acta Pharmaceutica Sinica B (November 2022)
Article in Expert Opinion on Drug Safety (May 2022)
Article in Expert Opinion on Drug Safety (November 2021)